Microbiology Spectrum,
Год журнала:
2023,
Номер
11(3)
Опубликована: Апрель 6, 2023
The
antioxidant
defense
system
plays
a
major
function
in
protecting
the
organism
against
oxidative
damage
caused
by
free
radicals.
COVID-19
patients
often
present
with
biochemical
characteristics
of
uncontrolled
pro-oxidative
responses
respiratory
tract.
Antioxidants,
Год журнала:
2021,
Номер
10(11), С. 1677 - 1677
Опубликована: Окт. 25, 2021
Even
though
COVID-19
is
mostly
well-known
for
affecting
respiratory
pathology,
it
can
also
result
in
several
extrapulmonary
manifestations,
leading
to
multiorgan
damage.
A
recent
reported
case
of
SARS-CoV-2
myocarditis
with
cardiogenic
shock
showed
a
signature
myocardial
and
kidney
ferroptosis,
novel,
iron-dependent
programmed
cell
death.
The
term
ferroptosis
was
coined
the
last
decade
describe
form
death
induced
by
small
molecule
erastin.
As
specific
inducer
erastin
inhibits
cystine-glutamate
antiporter
system
Xc-,
blocking
transportation
into
cytoplasm
cystine,
precursor
glutathione
(GSH)
exchange
glutamate
consequent
malfunction
GPX4.
Ferroptosis
promoted
intracellular
iron
overload
accumulation
polyunsaturated
fatty
acids
(PUFA)-derived
lipid
peroxides.
Since
depletion
GSH,
inactivation
GPX4,
altered
metabolism,
upregulation
PUFA
peroxidation
reactive
oxygen
species
are
peculiar
signs
COVID-19,
there
possibility
that
may
trigger
cells
multiple
organs,
thus
contributing
Here,
we
review
molecular
mechanisms
its
possible
relationship
infection
Finally,
analyze
potential
interventions
combat
and,
therefore,
reduce
Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Июнь 25, 2021
To
characterize
transcriptomic
changes
in
endothelial
cells
(ECs)
infected
by
coronaviruses,
and
stimulated
DAMPs,
the
expressions
of
1311
innate
immune
regulatomic
genes
(IGs)
were
examined
28
EC
microarray
datasets
with
7
monocyte
as
controls.
We
made
following
findings:
The
majority
IGs
are
upregulated
first
12
hours
post-infection
(PI),
maintained
until
48
PI
human
microvascular
middle
east
respiratory
syndrome-coronavirus
(MERS-CoV)
(an
model
for
COVID-19).
modulated
21
various
PAMPs/DAMPs,
including
LPS,
LPC,
shear
stress,
hyperlipidemia
oxLDL.
Upregulation
many
such
nucleic
acid
sensors
shared
between
ECs
MERS-CoV
those
PAMPs
DAMPs.
Human
heart
mouse
aortic
express
all
four
types
coronavirus
receptors
ANPEP,
CEACAM1,
ACE2,
DPP4
virus
entry
facilitator
TMPRSS2
(heart
EC);
most
replication-transcription
protein
complexes
expressed
HMEC,
which
contribute
to
viremia,
thromboembolism,
cardiovascular
comorbidities
COVID-19.
have
novel
trained
immunity
(TI),
subsequent
inflammation
is
enhanced.
Upregulated
proinflammatory
cytokines
TNFα,
IL6,
CSF1
CSF3
TI
marker
IL-32
well
metabolic
enzymes
epigenetic
indicate
function
HMEC
MERS-CoV,
may
drive
cytokine
storms.
demonstrate
a
promoting
myelopoiesis.
Mechanistically,
ER
stress
ROS,
together
decreased
mitochondrial
OXPHOS
complexes,
facilitate
response
TI.
Additionally,
an
increase
regulators
mitotic
catastrophe
cell
death,
apoptosis,
ferroptosis,
inflammasomes-driven
pyroptosis
upregulation
pro-thrombogenic
factors
thromboembolism
potential.
Finally,
NRF2-suppressed
ROS
regulate
responses,
TI,
thrombosis,
death.
These
results
provide
insights
on
roles
infections
COVID-19,
diseases
(CVD),
inflammation,
transplantation,
autoimmune
disease
cancers.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(4), С. 2360 - 2360
Опубликована: Фев. 21, 2022
The
review
presents
the
latest
data
on
role
of
selenium-containing
agents
in
regulation
diseases
immune
system.
We
mainly
considered
contributions
compounds
such
as
sodium
selenite,
methylseleninic
acid,
selenomethionine,
and
methylselenocysteine,
well
selenoproteins
selenium
nanoparticles
defense
mechanisms
against
various
viral
infections,
including
coronavirus
infection
(COVID-19).
A
complete
description
available
for
each
above
underlying
processes
with
active
participation
these
agents,
their
therapeutic
pharmacological
potential,
is
presented.
main
purpose
this
to
systematize
information,
supplemented
by
obtained
our
laboratory,
important
all
processes.
In
addition,
presented
information
makes
it
possible
understand
key
differences
action
compounds,
depending
chemical
physical
properties,
which
obtaining
a
holistic
picture
prospects
creating
drugs
based
them.
Drug Design Development and Therapy,
Год журнала:
2022,
Номер
Volume 16, С. 685 - 715
Опубликована: Март 1, 2022
Abstract:
The
rising
outbreak
of
SARS-CoV-2
continues
to
unfold
all
over
the
world.
development
novel
effective
antiviral
drugs
fight
against
is
a
time
cost.
As
result,
some
specific
FDA-approved
have
already
been
repurposed
and
authorized
for
COVID-19
treatment.
used
were
either
or
non-antiviral
drugs.
Accordingly,
present
review
thoroughly
focuses
on
repurposing
efficacy
these
including
clinical
trials
experienced,
combination
therapies
used,
methods
followed
treatment,
their
future
perspective.
Therefore,
drug
was
regarded
as
an
avenue
Recently,
molnupiravir
prodrug
medication
that
approved
in
United
Kingdom
November
2021
treatment
COVID-19.
On
other
hand,
PF-07321332
oral
developed
by
Pfizer.
For
COVID-19,
PF-07321332/ritonavir
Phase
III
studies
marketed
Paxlovid.
Herein,
we
represented
almost
history
combating
from
recently
available
anti-SARS-CoV-2
candidates,
new
hope
end
current
pandemic.
Graphical
Keywords:
SARS-CoV-2,
repurposing,
trials,
molnupiravir,
paxlovid
Microbiology Spectrum,
Год журнала:
2023,
Номер
11(3)
Опубликована: Апрель 6, 2023
The
antioxidant
defense
system
plays
a
major
function
in
protecting
the
organism
against
oxidative
damage
caused
by
free
radicals.
COVID-19
patients
often
present
with
biochemical
characteristics
of
uncontrolled
pro-oxidative
responses
respiratory
tract.